Aryl hydrocarbon receptor control of a disease tolerance defence pathway.
Aryl hydrocarbon receptor control of a disease tolerance defence pathway.
复制标题
DOI:
10.1038/nature13323
复制
发表时间:
2014-07-10
期刊:
影响因子:
64.8
通讯作者:
Puccetti P
中科院分区:
文献类型:
--
作者:
Bessede A;Gargaro M;Pallotta MT;Matino D;Servillo G;Brunacci C;Bicciato S;Mazza EM;Macchiarulo A;Vacca C;Iannitti R;Tissi L;Volpi C;Belladonna ML;Orabona C;Bianchi R;Lanz TV;Platten M;Della Fazia MA;Piobbico D;Zelante T;Funakoshi H;Nakamura T;Gilot D;Denison MS;Guillemin GJ;DuHadaway JB;Prendergast GC;Metz R;Geffard M;Boon L;Pirro M;Iorio A;Veyret B;Romani L;Grohmann U;Fallarino F;Puccetti P
Disease tolerance is the ability of the host to reduce the impact of infection on host fitness. Analysis of disease tolerance pathways could provide new approaches for treating infections and other inflammatory diseases. Typically, an initial exposure to bacterial lipopolysaccharide (LPS) induces a state of refractoriness to further LPS challenge (“endotoxin tolerance”). We found that a first exposure to LPS activated the ligand-operated transcription factor aryl hydrocarbon receptor (AhR) and the hepatic enzyme tryptophan 2,3-dioxygenase 2, which provided an activating ligand to the former, to downregulate early inflammatory gene expression. However, on LPS rechallenge, AhR engaged in long-term regulation of systemic inflammation only in the presence of indoleamine 2,3-dioxygenase 1 (IDO1). AhR complex-associated Src kinase activity promoted IDO1 phosphorylation and signaling ability. The resulting endotoxin-tolerant state was found to protect mice against immunopathology in gram-negative and gram-positive infections, pointing to a role for AhR in contributing to host fitness.
登录
查看更多内容
影响因子:
4.4
作者:
Jung, In Duk;Lee, Min-Goo;Park, Yeong-Min
通讯作者:
Park, Yeong-Min
影响因子:
30.5
作者:
Fallarino, F;Grohmann, U;Puccetti, P
通讯作者:
Puccetti, P
影响因子:
30.5
作者:
Grohmann, U;Orabona, C;Puccetti, P
通讯作者:
Puccetti, P
影响因子:
3
作者:
Dong, Bin;Cheng, Wei;Li, Wen;Zheng, Jie;Wu, Dalei;Matsumura, Fumio;Vogel, Christoph Franz Adam
通讯作者:
Vogel, Christoph Franz Adam
DOI:
10.1084/jem.20090560
发表时间:
2009-08-31
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Kimura A;Naka T;Nakahama T;Chinen I;Masuda K;Nohara K;Fujii-Kuriyama Y;Kishimoto T
通讯作者:
Kishimoto T